AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Quality of Life Validation in Laryngitis
Phase 4
Completed
- Conditions
- Laryngopharyngeal Reflux (LPR)
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2009-06-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 90
- Registration Number
- NCT00641264
Factorial Study of Metoprolol Succinate TOPROL-XL (324A)
Phase 3
Completed
- Conditions
- High Blood Pressure (Hypertension).
- Interventions
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1900
- Registration Number
- NCT00642096
Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children
Phase 4
Completed
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 380
- Registration Number
- NCT00641472
Inhaled Steroid Treatment as Regular Therapy in Early Asthma
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 6800
- Registration Number
- NCT00641914
Children, Perennial Allergic Rhinitis (PAR), l-t Growth
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 209
- Registration Number
- NCT00641212
Rhinocort Aqua Versus Placebo and Fluticasone Propionate
Phase 3
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 750
- Registration Number
- NCT00641680
Adults With Moderate to Severe Asthma
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 900
- Registration Number
- NCT00642122
New Nasal Applicator / New Formulation - User Study
Phase 2
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: PlaceboDevice: Budesonide
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 200
- Registration Number
- NCT00641979
New Version Pulmicort Turbuhaler USA Adults
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 525
- Registration Number
- NCT00642187
Assess the Efficacy and Safety of Rhinocort Aqua
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 650
- Registration Number
- NCT00641693
© Copyright 2025. All Rights Reserved by MedPath